TE_7295
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1HS_5end |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | LSAMP-AS1, - |
| Class | Chimeric, Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 191.61 |
| Counts of samples | TCGA_tumor:169; TCGA_normal:0; GTEx:0 |
| TSS | chr3(+):116209038 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_7295.1 | LSAMP-AS1 | Chimeric | Non-coding | Non-coding | chr3(+):116209039,116209166,116299635,116299899,116354210,116354280,116367942,116368035,116368143,116368271,116369831,116369851 |
| teRNA_7295.2 | LSAMP-AS1 | Chimeric | Non-coding | Non-coding | chr3(+):116209039,116209166,116299635,116299899,116354210,116354280,116368143,116368271,116369831,116369851 |
| teRNA_7295.3 | LSAMP-AS1 | Chimeric | Non-coding | Non-coding | chr3(+):116209039,116209166,116299635,116299899,116354210,116354269,116367942,116368035,116368143,116368271,116369831,116369851 |
| teRNA_7295.4 | - | Intergenic | Non-coding | Non-coding | chr3(+):116209039,116209166,116209312,116209450,116209797,116209817 |
| teRNA_7295.5 | LSAMP-AS1 | Chimeric | Non-coding | Non-coding | chr3(+):116209039,116209166,116354210,116354269,116367942,116368035,116368143,116368271,116369831,116369851 |
| teRNA_7295.6 | LSAMP-AS1 | Chimeric | Non-coding | Non-coding | chr3(+):116209039,116209166,116354210,116354280,116367942,116368035,116368143,116368271,116369831,116369851 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
